Axcella Health Inc.

1.96+0.0400+2.08%Vol 45.30K1Y Perf -53.28%
Jun 27th, 2022 16:00 DELAYED
BID1.80 ASK2.00
Open1.92 Previous Close1.92
Pre-Market- After-Market-
 - -  - -%
Target Price
10.83 
Analyst Rating
Moderate Buy 1.57
Potential %
452.55 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/14/14 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/51/51 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/45/45 
Income Ranking
 —    -
Price Range Ratio 52W %
17.63 
Earnings Rating
Neutral
Market Cap71.43M 
Earnings Date
4th Aug 2022
Alpha-0.05 Standard Deviation0.20
Beta1.51 

Today's Price Range

1.851.98

52W Range

1.354.81

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
1.55%
1 Month
0.00%
3 Months
-29.24%
6 Months
-10.91%
1 Year
-53.28%
3 Years
-78.95%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
AXLA1.960.04002.08
AAPL141.660.00000.00
GOOG2 332.45-38.3100-1.62
MSFT264.89-2.8100-1.05
XOM89.032.13002.45
WFC40.24-0.5200-1.28
JNJ182.12-0.1700-0.09
FB196.640.99000.51
GE66.71-0.2900-0.43
JPM116.38-0.9400-0.80
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.38-0.46-21.05
Q04 2021-0.43-0.46-6.98
Q03 2021-0.45-0.418.89
Q02 2021-0.42-0.420.00
Q01 2021-0.42-0.404.76
Q04 2020-0.36-0.40-11.11
Q03 2020-0.38-0.3410.53
Q02 2020-0.52-0.487.69
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.385.00Positive
9/2022 QR-0.355.41Positive
12/2022 FY-1.516.21Positive
12/2023 FY-1.3315.82Positive
Next Report Date4th Aug 2022
Estimated EPS Next Report-0.38
Estimates Count6
EPS Growth Next 5 Years %-
Volume Overview
Volume45.30K
Shares Outstanding36.45K
Shares Float18.10M
Trades Count312
Dollar Volume87.99K
Avg. Volume69.12K
Avg. Weekly Volume61.75K
Avg. Monthly Volume78.21K
Avg. Quarterly Volume67.40K

Axcella Health Inc. (NASDAQ: AXLA) stock closed at 1.96 per share at the end of the most recent trading day (a 2.08% change compared to the prior day closing price) with a volume of 45.30K shares and market capitalization of 71.43M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 66 people. Axcella Health Inc. CEO is William R. Hinshaw.

The one-year performance of Axcella Health Inc. stock is -53.28%, while year-to-date (YTD) performance is -6.22%. AXLA stock has a five-year performance of %. Its 52-week range is between 1.35 and 4.81, which gives AXLA stock a 52-week price range ratio of 17.63%

Axcella Health Inc. currently has a PE ratio of -1.10, a price-to-book (PB) ratio of 3.38, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -84.09%, a ROC of -90.50% and a ROE of -149.60%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Axcella Health Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.38 for the next earnings report. Axcella Health Inc.’s next earnings report date is 04th Aug 2022.

The consensus rating of Wall Street analysts for Axcella Health Inc. is Moderate Buy (1.57), with a target price of $10.83, which is +452.55% compared to the current price. The earnings rating for Axcella Health Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Axcella Health Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Axcella Health Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 16.04, ATR14 : 0.23, CCI20 : -83.98, Chaikin Money Flow : 0.03, MACD : 0.00, Money Flow Index : 45.92, ROC : -20.33, RSI : 46.69, STOCH (14,3) : 12.12, STOCH RSI : 0.26, UO : 42.91, Williams %R : -87.88), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Axcella Health Inc. in the last 12-months were: David R. Epstein (Buy at a value of $50 000), David R. Epstein (Option Excercise at a value of $0), Gary P. Pisano (Option Excercise at a value of $22 801), Margaret Koziel (Sold 553 shares of value $1 030 ), Paul Fehlner (Buy at a value of $20 000), Robert Crane (Buy at a value of $75 000), William R. Hinshaw (Buy at a value of $25 000), William R. Hinshaw (Option Excercise at a value of $0), William R. Hinshaw (Sold 33 180 shares of value $54 787 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (85.71 %)
6 (85.71 %)
7 (87.50 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (14.29 %)
1 (14.29 %)
1 (12.50 %)
Summary RatingStrong Buy
1.57
Strong Buy
1.57
Strong Buy
1.50

Axcella Health Inc.

Axcella Health Inc a biotechnology company involved in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism. Its AXA candidates are generated from its proprietary, human-focused AXA Development Platform and harness the power of endogenous metabolic modulators, or EMMs. The company's pipeline comprises five programs focused on the metabolic functions of the liver, muscle, and blood.

CEO: William R. Hinshaw

Telephone: +1 857 320-2200

Address: 840 Memorial Drive, Cambridge 02139, MA, US

Number of employees: 66

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

47%53%

Bearish Bullish

56%44%

Bearish Bullish

60%40%

TipRanks News for AXLA

Tue, 31 May 2022 12:15 GMT Axcella Health (AXLA) Receives a Buy from Noble Financial

- TipRanks. All rights reserved.

Mon, 09 May 2022 10:27 GMT Axcella Health (AXLA) Receives a Buy from H.C. Wainwright

- TipRanks. All rights reserved.

Sun, 08 May 2022 15:16 GMT Axcella Health (AXLA) Receives a Buy from SVB Securities

- TipRanks. All rights reserved.

Thu, 31 Mar 2022 12:37 GMT Axcella Health (AXLA) Received its Third Buy in a Row

- TipRanks. All rights reserved.

Tue, 15 Feb 2022 10:31 GMT Axcella Health (AXLA) Gets a Buy Rating from H.C. Wainwright

- TipRanks. All rights reserved.

Wed, 12 Jan 2022 11:46 GMT Axcella Health (AXLA) Gets a Buy Rating from Wedbush

- TipRanks. All rights reserved.

News

Stocktwits